Yiwei Huang1, Mengnan Zhao1, Jiacheng Yin1, Tao Lu1, Xiaodong Yang1, Guangda Yuan2, Ming Li3, Yu Liu1, Cheng Zhan4, Qun Wang5. 1. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, China. 2. Department of Thoracic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China. 3. Eight-year Program Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China. 4. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, China. czhan10@fudan.edu.cn. 5. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, China. wang.qun@zs-hospital.sh.cn.
Abstract
BACKGROUND: Colorectal cancer (CRC) has a high worldwide incidence with a tendency to metastasize to the lungs. We aimed to identify clinical factors related to lung metastasis (LM) and analyze the prognosis of patients after LM. METHODS: Multivariate logistic regression analysis was used to identify risk factors for LM from CRC. Univariate and multivariate Cox proportional hazard models were performed to identify potentially important prognostic factors for patients with LM. RESULTS: Age (p = 0.010), tumor size (p < 0.001), T stage (p < 0.001), N stage (p < 0.001), race (p < 0.001), tumor site (p < 0.001), liver metastasis (p < 0.001), brain metastasis (p < 0.001), bone metastasis (p < 0.001), serum levels of carcinoembryonic antigen (CEA) (p < 0.001), and circumferential resection margin (CRM) (p < 0.001) were associated with a risk of LM from CRC. All factors (all, p < 0.001) except tumor size (p = 0.095) and race (p = 0.650) were related to the overall survival of patients. Two nomograms were formulated to visually predict lung metastasis risk and 1-, 3-, and 5- year overall survivals for patients with LM. The concordance indices were 0.754 and 0.749, respectively. CONCLUSIONS: Age, tumor size, histological grade, serum levels of CEA, tumor site, surgery modalities of CRC, CRM, number of positive lymph nodes, and chemotherapy were independent risk factors for LM from CRC. The nomograms we developed can be effectively used to forecast the risk of LM and predict the survival for LM from CRC.
BACKGROUND:Colorectal cancer (CRC) has a high worldwide incidence with a tendency to metastasize to the lungs. We aimed to identify clinical factors related to lung metastasis (LM) and analyze the prognosis of patients after LM. METHODS: Multivariate logistic regression analysis was used to identify risk factors for LM from CRC. Univariate and multivariate Cox proportional hazard models were performed to identify potentially important prognostic factors for patients with LM. RESULTS: Age (p = 0.010), tumor size (p < 0.001), T stage (p < 0.001), N stage (p < 0.001), race (p < 0.001), tumor site (p < 0.001), liver metastasis (p < 0.001), brain metastasis (p < 0.001), bone metastasis (p < 0.001), serum levels of carcinoembryonic antigen (CEA) (p < 0.001), and circumferential resection margin (CRM) (p < 0.001) were associated with a risk of LM from CRC. All factors (all, p < 0.001) except tumor size (p = 0.095) and race (p = 0.650) were related to the overall survival of patients. Two nomograms were formulated to visually predict lung metastasis risk and 1-, 3-, and 5- year overall survivals for patients with LM. The concordance indices were 0.754 and 0.749, respectively. CONCLUSIONS: Age, tumor size, histological grade, serum levels of CEA, tumor site, surgery modalities of CRC, CRM, number of positive lymph nodes, and chemotherapy were independent risk factors for LM from CRC. The nomograms we developed can be effectively used to forecast the risk of LM and predict the survival for LM from CRC.
Authors: Chang Hyun Kim; Jung Wook Huh; Hun Jin Kim; Sang Woo Lim; Sang Yun Song; Hyeong Rok Kim; Kook Joo Na; Young Jin Kim Journal: Dis Colon Rectum Date: 2012-04 Impact factor: 4.585
Authors: S Salah; K Watanabe; S Welter; J S Park; J W Park; J Zabaleta; F Ardissone; J Kim; M Riquet; K Nojiri; M Gisabella; S Y Kim; K Tanaka; B Al-Haj Ali Journal: Ann Oncol Date: 2012-04-29 Impact factor: 32.976
Authors: Shanda H Blackmon; Elizabeth H Stephens; Arlene M Correa; Wayne Hofstetter; Min P Kim; Reza J Mehran; David C Rice; Jack A Roth; Stephen G Swisher; Garrett L Walsh; Ara A Vaporciyan Journal: Ann Thorac Surg Date: 2012-10-11 Impact factor: 4.330
Authors: Marco Tampellini; Azzurra Ottone; Elisa Bellini; Irene Alabiso; Chiara Baratelli; Raffaella Bitossi; Maria P Brizzi; Anna Ferrero; Elisa Sperti; Francesco Leone; Stefania Miraglia; Laura Forti; Erica Bertona; Francesco Ardissone; Alfredo Berruti; Oscar Alabiso; Massimo Aglietta; Giorgio V Scagliotti Journal: Oncologist Date: 2012-09-06
Authors: Marc Riquet; Christophe Foucault; Aurélie Cazes; Emmanuel Mitry; Antoine Dujon; Françoise Le Pimpec Barthes; Jacques Médioni; Philippe Rougier Journal: Ann Thorac Surg Date: 2010-02 Impact factor: 4.330
Authors: Ameera S Balhareth; Abdullah S AlQattan; Hassan M Alshaqaq; Abdullah M Alkhalifa; Alaa A Al Abdrabalnabi; Muna S Alnamlah; Deborah MacNamara Journal: Ann Med Surg (Lond) Date: 2022-04-04